\require{mhchem}Misfit phase \ce{(BiSe)_{1.10}NbSe2} as the origin of superconductivity in nobium-doped bismuth selenide

\require{mhchem}Topological superconductivity is of great contemporary interest and has been proposed in doped \ce{Bi2Se3} in which electron-donating atoms such as Cu, Sr or Nb have been intercalated into the \ce{Bi2Se3} structure. For \ce{Nb_{x}Bi2Se3}, with $\text{T}_\text{c} \sim 3 \ \text{K}$, it is assumed in the literature that Nb is inserted in the van der Waals gap. However, in this work an alternative origin for the superconductivity in Nb-doped \ce{Bi2Se3} is established. In contrast to previous reports, it is deduced that Nb intercalation in \ce{Bi2Se3} does not take place. Instead, the superconducting behaviour in samples of nominal composition \ce{Nb_{x}Bi2Se3} results from the \ce{(BiSe)_{1.10}NbSe2} misfit phase that is present in the sample as an impurity phase for small $x$ ($0.01 \leq x \leq 0.10$) and as a main phase for large $x$ ($x = 0.50$). The structure of this misfit phase is studied in detail using a combination of X-ray diffraction and transmission electron microscopy techniques

Complex magnetic ordering in the oxide selenide Sr2Fe3Se2O3

Sr2Fe3Se2O3 is a localised-moment iron oxide selenide in which two unusual coordinations for Fe2+ ions form two sublattices in a 2:1 ratio. In the paramagnetic region at room temperature the compound adopts the crystal structure first reported for Sr2Co3S2O3, crystallising in space group Pbam with a = 7.8121 Å, b = 10.2375 Å, c = 3.9939 Å and Z = 2. The sublattice occupied by two thirds of the iron ions (Fe2 site) is formed by a network of distorted mer-[FeSe3O3] octahedra linked via shared Se2 edges and O vertices forming layers, which connect to other layers by shared Se vertices. As shown by magnetometry, neutron powder diffraction and Mössbauer spectroscopy measurements, these moments undergo long range magnetic ordering below TN1 = 118 K, initially adopting a magnetic structure with a propagation vector (½–δ, 0, ½) (0 ≤ ≤ 0.1) which is incommensurate with the nuclear structure and described in the Pbam1’(a01/2)000s magnetic superspace group, until at 92 K (TINC) there is a first order lock-in transition to a structure in which these Fe2 moments form a magnetic structure with a propagation vector (½ , 0, ½) which may be modelled using a 2a × b × 2c expansion of the nuclear cell in space group 36.178 Bab21m (BNS notation). Below TN2 = 52 K the remaining third of the Fe2+ moments (Fe1 site) which are in a compressed trans-[FeSe4O2] octahedral environment undergo long range ordering, as is evident from the magnetometry, the Mössbauer spectra and the appearance of new magnetic Bragg peaks in the neutron diffractograms. The ordering of the second set of moments on the Fe1 sites results in a slight re-orientation of the majority moments on the Fe2 sites. The magnetic structure at 1.5 K is described by a 2a × 2b × 2c expansion of the nuclear cell in space group 9.40 Iab (BNS notation)

Anion redox as a means to ferive layered manganese oxychalcogenides with exotic intergrowth structures

Topochemistry enables step-by-step conversions of solid-state materials often leading to metastable structures that retain initial structural motifs. Recent advances in this field revealed many examples where relatively bulky anionic constituents were actively involved in redox reactions during (de)intercalation processes. Such reactions are often accompanied by anion-anion bond formation, which heralds possibilities to design novel structure types disparate from known precursors, in a controlled manner. Here we present the multistep conversion of layered oxychalcogenides Sr2MnO2Cu1.5Ch2 (Ch = S, Se) into Cu-deintercalated phases where antifluorite type [Cu1.5Ch2]2.5- slabs collapsed into two-dimensional arrays of chalcogen dimers. The collapse of the chalcogenide layers on deintercalation led to various stacking types of Sr2MnO2Ch2 slabs, which formed polychalcogenide structures unattainable by conventional high-temperature syntheses. Anion-redox topochemistry is demonstrated to be of interest not only for electrochemical applications but also as a means to design complex layered architectures

Persistence of onchocerciasis and associated dermatologic and ophthalmic pathologies after 27 years of ivermectin mass drug administration in the middle belt of Ghana

Objectives: There is a pressing need to regularly evaluate the progress of onchocerciasis elimination programmes to timely identify and mitigate potential risks hindering the reaching of the 2030 targets proposed by the World Health Organization (WHO) in its roadmap on neglected tropical diseases (NTDs). We determined the prevalence of onchocerciasis and associated dermatological and ophthalmological manifestations in six endemic communities in the Bono Region of Ghana after 27 years of ivermectin mass treatment. Methods: In a cross-sectional study, 564 participants aged ≥5 years were enrolled (49.1% females), with a median age of 26 (range: 5–89) years. In 54% and 47%, skin-snip microscopy and Ov16 rapid diagnostic tests were performed, respectively. Skin disease was determined using the WHO Skin NTD App. Visual function assessments included tests of visual acuity. Results: The overall microfilarial prevalence was 12.5% (38/305) and Ov16 seroprevalence was 24.2% (64/265). Severe itching was recorded in 24.3%, acute papular onchodermatitis in 52.8%, chronic papular onchodermatitis in 12.5%, lichenified onchodermatitis in 0.7%, skin atrophy in 11.3%, depigmentation in 1.7% and palpable nodules in 5.3%. Of the 301 persons in which visual acuity was examined, 17% were visually impaired and 5.3% were blind and 47.3% presented with cataract. Chronic papular onchodermatitis, lichenified onchodermatitis, depigmentation and visual impairment were significantly associated with the presence of skin microfilariae and Ov16 seropositivity. Conclusions: The persistence of Onchocerca volvulus infection and onchocerciasis-associated dermatological and ophthalmological pathologies after prolonged treatment is of concern. There is a need to include morbidity management in onchocerciasis elimination programmes and understand better patterns of treatment coverage, adherence and actual intake of ivermectin

Impact of ordering on the reactivity of mixed crystals of topological insulators with anion substitution Bi2SeTe2 and Sb2SeTe2

Three dimensional topological insulators TIs are exotic materials with unique properties. Tetradymite type binary chalcogenides of bismuth and antimony, as well as their mixed crystals, belong to prototypical TIs. Potential device applications of these materials require in depth knowledge of their stability in the ambient atmosphere and other media maintained during their processing. Here we investigated the reactivity of mixed crystals with anion substitution, Bi2 Se1 xTex 3 and Sb2 Se1 xTex 3, towards molecular oxygen using both in situ and ex situ X ray photoelectron spectroscopy. The results indicate that, in contrast to cation substitution, partial substitution of tellurium by selenium atoms leads to anomalously high surface reactivity, which even exceeds that of the most reactive binary constituent. We attribute this effect to anion ordering that essentially modifies the bond geometry, especially the respective bond angles as modeled by DF

Selective reduction of layers at low temperature in artificial superlattice thin films

Reduction and oxidation in transition-metal oxides are keys to develop technologies related to energy and the environment. Here we report the selective topochemical reduction observed when artificial superlattices with transition-metal oxides are treated at a temperature below 300 °C with CaH2. [CaFeO2]m/[SrTiO3]n infinite-layer/perovskite artificial superlattice thin films were obtained by low-temperature reduction of [CaFeO2.5]m/[SrTiO3]n brownmillerite/perovskite artificial superlattice thin films. By the reduction only the CaFeO2.5 layers in the artificial superlattices were reduced to the CaFeO2 infinite layers whereas the SrTiO3 layers were unchanged. The observed low-temperature reduction behaviors strongly suggest that the oxygen ion diffusion in the artificial superlattices is confined within the two-dimensional brownmillerite layers. The reduced artificial superlattice could be reoxidized, and thus, the selective reduction and oxidation of the constituent layers in the perovskite-structure framework occur reversibly

Onchocerciasis-associated epilepsy: an explorative case-control study with viral metagenomic analyses on Onchocerca volvulus [version 2; peer review: 2 approved]

Background A high prevalence of onchocerciasis-associated epilepsy (OAE) has been observed in onchocerciasis-endemic areas with high ongoing Onchocerca volvulus transmission. However, the pathogenesis of OAE remains to be elucidated. We hypothesise that the O. volvulus virome could be involved in inducing epilepsy. With this study, we aim to describe the O. volvulus virome and identify potential neurotropic viruses linked to OAE. Methods In Maridi County, an onchocerciasis endemic area in South Sudan with a high prevalence of OAE, we will conduct an exploratory case-control study enrolling 40 persons aged 12 years and above with palpable onchocerciasis nodules. Cases will be participants with OAE (n=20), who will be age- and village-matched with controls without epilepsy (n=20). For each study participant, two skin snips at the iliac crest will be obtained to collect O. volvulus microfilariae, and one nodulectomy will be performed to obtain adult worms. A viral metagenomic study will be conducted on microfilariae and adult worms, and the O. volvulus virome of persons with and without OAE will be compared. The number, size, and localisation of onchocerciasis nodules in persons with and without OAE will be described. Moreover, the pre- and post-nodulectomy frequency of seizures in persons with OAE will be compared. Ethics and dissemination The protocol has been approved by the Ethics Committee of the University of Antwerp and the Ministry of Health of South Sudan. Findings will be disseminated nationally and internationally via meetings and peer-reviewed publications. Registration ClinicalTrials.gov registration NCT05868551 (https://clinicaltrials.gov/study/NCT05868551). Protocol version 1.1, dated 09/05/2023